Congratulations to Dr. Juan Pablo de Rivero Vaccari and Dr. Alejandro Martín-Montalvo who won the 2024 MDPI Topics Award for their Topic “Inflammaging: The Immunology of Aging”.

	Name: Dr. Juan Pablo de Rivero Vaccari Affiliation: Department of Neurological Surgery and The Miami Project to Cure Paralysis, University of Miami, Miami, FL, USA  Research interests: drug discovery; biomarkers; neurodegenerative diseases; CNS injury; neuroprotection; inflammation; inflammasome; pyroptosis
	Name: Dr. Alejandro Martín-Montalvo Affiliation: Andalusian Center for Molecular Biology and Regenerative Medicine, CABIMER (Junta de Andalucía-CSIC-Universidad de Sevilla-Universidad Pablo de Olavide), Calle Américo Vespucio, 24, 41092 Sevilla, Spain Research interests: aging; hepatic cancer; metabolism; endocrinology

The following is a short interview with Dr. Juan Pablo de Rivero Vaccari and Dr. Alejandro Martín-Montalvo:

1. Could you please briefly introduce your winning Topic to our readers?
Our Topic focuses on the immunology of aging. The aim was to bring together emerging research in the field of age-related inflammation or inflammaging and create a space in which researchers could explain their new ideas and results to the scientific community.

2. What has been your impression of the publishing experience with MDPI Topics? Do you have any suggestions for improving the development of MDPI Topics?
Our experience has been very positive; the editorial team was efficient and supportive throughout the process. Our suggestion is to keep working using this format.

3. What advice would you offer to young investigators who aspire to achieve similar recognition in their research careers?
Our advice would be to stay curious in everything they do. We have to remain open to unexpected findings and discuss findings with our colleagues. Recognition normally follows when passion and rigor drive your research.

4. Which research topics do you think will be of particular interest to the research community in the coming years?
We believe that we will see increasing interest in advanced therapies and biomarkers. Interdisciplinary work will also stay central in the future, allowing the development of complex projects that will have synergistic outputs. This will require a special emphasis on team science to answer more complex questions from different angles. In addition, we expect a deeper interest in how organs communicate with each other to modulate or even cause or worsen diseases in other organs, such as how the gut affects the brain or how the brain affects the heart.

5. What are your thoughts on the evolution of open access publishing in academia? How do you see it impacting the dissemination of future research?
Open access publishing is central to sharing scientific results. It allows researchers to access and build upon existing work globally. This system strengthens the visibility, transparency, and global reach of scientific discovery.

6. Do you have anything else you would like to share with readers?
We would like to express our gratitude to all the contributors and reviewers who made this Topic possible. We hope our readers find inspiration in this collection to continue to push their research in the field of aging forward.